Search by Symbol
View Universe
FINRA:SIPC

Taglich Brothers RSS









Disclaimer

 
Taglich's Company Profile for:

www.dermasciences.com

Receive email alerts for this company

Derma Sciences, Inc.

Symbol: DSCI
Analyst:  
Juan Noble
Taglich Rating:
   Speculative Buy
Price Target:   $.75
Time Horizon:   12 Months
Rating Established:   July 10, 2006
   
Price When Established:   $0.82
Most Recent Report: May 19, 2009
    Price When Issued: $0.32

Most Recent Update

Updated Earnings Note (Dated May 19, 2009)

What's New
New information will be posted soon...
Company Description
Derma Sciences, Inc. (OTC BB: DSCI), was established in 1984 to manufacture and market wound care products used to treat pressure ulcers, diabetic and venous ulcers, surgical incisions and serious burns. Since 1996, Derma Sciences has expanded its product line and manufacturing base through some acquisitions. The company’s production facilities are in Canada and China. Contractors in China are being used increasingly to perform the more costly sterilization procedures.

The company’s product line is sold mainly through distributors in the US and Canada to end users such as nursing homes and acute care hospitals, with some sales made to clinics and physicians’ offices.
Taglich Research Reports
Updated Earnings Note (Dated April 2, 2009)
Updated Research Report (Dated December 1, 2008)
Updated Earnings Note (Dated November 17, 2008)
Updated Research Report (Dated September 3, 2008)
Updated Earnings Note (Dated August 14, 2008)
Updated Research Report (Dated June 6, 2008)
Updated Earnings Note (Dated May 19, 2008)
Updated Earnings Note (Dated April 16, 2008)
Updated Earnings Note (Dated April 2, 2008)
Updated Research Report (Dated December 14, 2007)
Updated Earnings Note (Dated November 14, 2007)
Updated Research Report (Dated September 24, 2007)
Updated Research Report (Dated June 13, 2007)
Updated Research Report (Dated April 13, 2007)
Updated Research Report (Dated December 26, 2006)
Updated Research Report (Dated September 12, 2006)
Initial Research Report (Dated July 10, 2006)

All Research Reports are in Adobe Acrobat format.
(for the latest Adobe Acrobat reader click here)

*The information and statistical data contained herein have been obtained from sources, which we believe to be reliable but in no way are warranted by us as to accuracy or completeness. We do not undertake to advise you as to changes in figures or our views. This is not a solicitation of any order to buy or sell. Taglich Brothers, Inc. is fully disclosed with its clearing firm, Pershing, LLC, is not a market maker and does not sell to or buy from customers on a principal basis. The above statements are the opinion of Taglich Brothers, Inc. and are not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. There may be instances when fundamental, technical and quantitative opinions contained in the reports are not in concert. We, our affiliates, any officer, director or stockholder or any member of their families may from time to time purchase or sell any of the above-mentioned or related securities. Analysts and members of the Research Department are prohibited from buying or selling securities issued by the companies that Taglich Brothers, Inc. has a research relationship with, except if ownership of such securities was prior to the start of such relationship, then an Analyst or member of the Research Department may sell such securities after obtaining expressed written permission from the Director of Research. All research issued by Taglich Brothers, Inc. is based on public information. In April 2006, Taglich Brothers underwrote an offering of 7,548,064 Derma Sciences’ common shares at $0.60 per share and 1,887,016 warrants exercisable at $1.00 per share. In March, 2006, the company paid a monetary engagement fee of $21,000 (USD) for the first year of creation and dissemination of research reports and since July, 2007, has paid a monthly monetary fee of $1,750 (USD) to Taglich Brothers, Inc. for these services after the first year. For further information and Taglich Brothers, Inc. ownership data please refer to each individual report.

Send this Page to a friend

To send this page to a friend, just fill out the form below and press the "send it" button!

Your Name
Your E-mail
Your Friend's Name
Your Friend's E-mail
Market Data
Bloomberg
Hoover's Capsule
SEC Filings
Yahoo Finance
Taglich Covered Companies
AeroCentury Corp.
Anglo Swiss Resources, Inc.
Baldwin Technlogy Company, Inc
BioForce Nanosci. Holdings, Inc.
Carbiz, Inc.
Command Security Corp.
CTI Industries Corp
Derma Sciences, Inc.
DRI Corporation
Gulfstream International Group, Inc.
Hyperdynamics Corporation
INX, Inc.
Life Partners Holdings, Inc.
Lifeway Foods, Inc.
Littlefield Corporation
NeoGenomics, Inc.
Orchids Paper Products
Park City Group, Inc.
Patriot Scientific Corp.
Pressure BioSciences, Inc.
Radiant Logistics, Inc.
Simulations Plus, Inc.
SMF Energy Corporation
TranSwitch Corporation
UFP Technologies, Inc.
US 1 Industries, Inc.
Williams Controls, Inc.

This site is best viewed at 800x600 with: Internet Explorer Click Here for more information.
Ticker powered by TickerTech.com. Copyright © 2000 Ticker Technologies Inc., All Rights Reserved. Quote data at least 20 minutes delayed. Please read other important disclaimer information.